Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-04-000013
Filing Date
2004-03-16
Accepted
2004-03-16 12:49:32
Documents
1
Period of Report
2004-03-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 16744
  Complete submission text file 0000882796-04-000013.txt   18526
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O BIOCRYST PHARMACEUTICALS INC 2190 PARKWAY LAKE DRIVE BIRMINGHAM AL 35244 2054444600
DARWIN MICHAEL A (Reporting) CIK: 0001211035 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 04671747